Tag: cases

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

Scottsdale, ARIZONA, June 08, 2026 (GLOBE NEWSWIRE) -- Warnock Mackinlay Law, a Scottsdale-based personal injury law firm serving clients throughout Arizona, has expanded its focus on legal representation for individuals and families affected by wrongful death incidents and truck accidents across Chandler, Peoria, Tempe, Glendale, and surrounding communities. As commercial transportation activity continues to grow across the state, serious truck collisions and fatal accidents remain significant concerns for Arizona residents. The firm continues to assist injury victims and surviving family members in pursuing accountability and financial recovery following catastrophic collisions and preventable tragedies.

KUALA LUMPUR, Malaysia, June 08, 2026 (GLOBE NEWSWIRE) -- At the Science x AI Summit 2026 held in Silicon Valley on May 12, the latest technological advances in the global AI research and industrial communities became the focus of attention. Experts from Thian Ong Financial Academy joined the discussions as the scaling limits of large models, AI Agents, autonomous reasoning systems, and the development path of research-grade AI triggered extensive discussions among participating experts.

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Calix, Inc. (NYSE: CALX) between January 28, 2026 and April 21, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”), of the important July 13, 2026 lead plaintiff deadline.